Finn Sawyer Access to Cancer Testing Act

This bill requires Medicare, Medicaid, and CHIP to cover cancer diagnostic and laboratory tests (like genetic sequencing for cancer diagnosis and treatment monitoring) for patients. It defines these tests specifically and sets rules: Medicare pays 80% (or 100% for certain cases) of the test cost without deductibles, while Medicaid must cover them starting in 2027 and CHIP must cover them for children and pregnant women starting in 2025. Tests can only be provided once at diagnosis, once for recurrence, and as needed for treatment planning. The bill directly affects cancer patients enrolled in these federal health programs.